mobile
-
Extremities
Paragon 28 Adds Second Mobile Medical Education Lab Significantly Expanding Upon Wildly Successful Foot and Ankle Surgeon Training Program
ENGLEWOOD, Colo., November 13, 2023–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) is pleased to announce the addition of a second trailer…
Read More » -
Extremities
Paragon 28 Launches Mobile Medical Education Lab Tour, Expanding Opportunities for Foot and Ankle Surgeon Education
July 13, 2022 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot…
Read More » -
Hospitals
Mobile X-ray Leaps into the Future with New Innovations from Konica Minolta Healthcare
Dynamic Digital Radiography and the new glassless AeroDR flat panel detector will be available on the mKDR Xpress Mobile X-ray…
Read More » -
Recon
Smith+Nephew embarks on the OXINIUM™ Technology Tour of Change; a mobile learning exhibit to showcase the best performing bearing for total hip arthroplasty
LONDON, March 15, 2022 /PRNewswire/ — Smith+Nephew (LSE: SN,NYSE: SNN), the global medical technology business, today announces it has kicked-off the OXINIUM Technology…
Read More » -
Spine
Aurora Spine Launches Mobile App
CARLSBAD, CALIFORNIA–(Marketwired – Dec 5, 2016) – Aurora Spine Corporation (TSX VENTURE:ASG) announced today the launch of its new Aurora…
Read More » -
Financial
HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors
In today’s healthcare landscape, where costs are growing and margins are getting tighter, it can be challenging for doctors and…
Read More » -
Hospitals
TraumaCad Orthopedic Pre-operative Planning and Templating Solution Receives FDA Clearance on New Mobile Version
LAS VEGAS–(BUSINESS WIRE)–Voyant Health, a Brainlab Company, announced today that it has received FDA clearance onTraumaCad® Mobile, the mobile solution for…
Read More » -
Financial
Report: Clinical devices will drive mobile health market to $41.8B by 2023
Given the innovation learning curve the U.S. Food and Drug Administration has been working through, it’s not surprising that the…
Read More »